Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells–a review

L Bacakova, J Zarubova, M Travnickova… - Biotechnology …, 2018 - Elsevier
Stem cells can be defined as units of biological organization that are responsible for the
development and the regeneration of organ and tissue systems. They are able to renew their …

The secret life of exosomes: what bees can teach us about next-generation therapeutics

E Marbán - Journal of the american college of cardiology, 2018 - jacc.org
Mechanistic exploration has pinpointed nanosized extracellular vesicles, known as
exosomes, as key mediators of the benefits of cell therapy. Exosomes appear to recapitulate …

Chitosan as functional biomaterial for designing delivery systems in cardiac therapies

B Patel, R Manne, DB Patel, S Gorityala… - Gels, 2021 - mdpi.com
Cardiovascular diseases are a leading cause of mortality across the globe, and transplant
surgeries are not always successful since it is not always possible to replace most of the …

Therapeutic use of stem cells for myocardial infarction

M Madigan, R Atoui - Bioengineering, 2018 - mdpi.com
Myocardial infarction is a leading cause of morbidity and mortality worldwide. Although
medical and surgical treatments can significantly improve patient outcomes, no treatment …

Multifunctional conductive biomaterials as promising platforms for cardiac tissue engineering

A Mousavi, S Vahdat, N Baheiraei… - ACS biomaterials …, 2020 - ACS Publications
Adult cardiomyocytes are terminally differentiated cells that result in minimal intrinsic
potential for the heart to self-regenerate. The introduction of novel approaches in cardiac …

[HTML][HTML] Stem cell therapy for heart failure: Medical breakthrough, or dead end?

M Rheault-Henry, I White, D Grover… - World journal of stem …, 2021 - ncbi.nlm.nih.gov
Heart failure continues to be one of the leading causes of morbidity and mortality worldwide.
Myocardial infarction is the primary causative agent of chronic heart failure resulting in …

Ethical development of stem-cell-based interventions

A MacPherson, J Kimmelman - Nature Medicine, 2019 - nature.com
The process of developing new and complex stem-cell-based therapeutics is incremental
and requires decades of sustained collaboration among different stakeholders. In this …

Extracellular vesicles as therapeutic agents for cardiac fibrosis

RG Rogers, A Ciullo, E Marbán, AG Ibrahim - Frontiers in physiology, 2020 - frontiersin.org
Heart disease remains an increasing major public health challenge in the United States and
worldwide. A common end-organ feature in diseased hearts is myocardial fibrosis, which …

Isolation and characterization of cardiac mesenchymal stromal cells from endomyocardial bioptic samples of arrhythmogenic cardiomyopathy patients

CA Pilato, I Stadiotti, AS Maione, V Saverio… - JoVE (Journal of …, 2018 - jove.com
A normal adult heart is composed of several different cell types, among which cardiac
mesenchymal stromal cells represent an abundant population. The isolation of these cells …

The Role of blood-derived factors in protection and regeneration of aged tissues

AL Höving, KE Schmidt, B Kaltschmidt… - International Journal of …, 2022 - mdpi.com
Tissue regeneration substantially relies on the functionality of tissue-resident endogenous
adult stem cell populations. However, during aging, a progressive decline in organ function …